Actively Recruiting
Molecular Markes of Fibrosis of Endometriosis and Their Use in Predicting Disease Severity
Led by General University Hospital, Prague · Updated on 2023-08-31
120
Participants Needed
1
Research Sites
195 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The primary aim of the project is to analyse gene expression in individual types of ectopic endometrium (ovarian endometriosis, peritoneal endometriosis, deep infiltrating endometriosis) and compare it with gene expression in eutopic endometrium. The analysis focuses on the identification of genes with significantly increased expression in each type of ectopic endometrium and comparison of their expression with the degree of disease, ovarian reserve and clinical manifestations of the disease (pain, infertility).
CONDITIONS
Official Title
Molecular Markes of Fibrosis of Endometriosis and Their Use in Predicting Disease Severity
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 18 to 45 years
- Signed informed consent for the study
- No hormonal treatment for at least 3 months before the planned procedure
- For group A: laparoscopically and histologically confirmed diagnosis of endometriosis
- For group B: patients without endometriosis undergoing elective laparoscopic or hysteroscopic procedure for benign reasons
- Patients with malignant disease excluded
You will not qualify if you...
- No informed consent given
- Patients who do not meet inclusion criteria during surgery
- Younger than 18 years or older than 45 years
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
General University Hospital in Prague
Prague, Czechia, 12808
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here